InsiderTrades.com logo
"I've never seen anything bigger"
From Legacy Research   |   Ad
According to one Wall Street Legend, "for those who take early action, it could make 2021 one of your best years ever".
Watch more here!

AREC Insider Trading (Arecor Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £30,375
Insider Selling (Last 12 Months): GBX 0

Arecor Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Arecor Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arecor Therapeutics Share Price & Price History

Current Price: GBX 240
Price Change: ▼ Price Decrease of -1.44 (-0.60%)
As of 06/23/2021 10:00 PM ET

This chart shows the closing price history over time for AREC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The BIG CON “Screwing Americans”
From Stansberry   |   Ad
The rich and powerful are thrilled... Inflation is GREAT for them. It’s everyone else who’ll get screwed. But according to an ex-Wall Street vet, there’s actually a way for YOU to turn the tables – just make this one move before July 29th.
Click here to see why

Arecor Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/8/2021Andrew RichardsInsiderBuy12,500GBX 243£30,375
See Full Table
Insider Selling at Arecor Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Arecor Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Arecor Therapeutics (LON:AREC)

Arecor Therapeutics logo
Arecor Therapeutics PLC, a biopharmaceutical company, develops a portfolio of proprietary products in diabetes and other indications. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated formulation of rapid acting insulin that has been designed to accelerate the absorption of insulin post injection. The company was incorporated in 2021 is based in Little Chesterford, the United Kingdom.
Read More on Arecor Therapeutics

Today's Range

Now: GBX 240
Low: 239.11
High: 241.44

50 Day Range

MA: N/A

52 Week Range

Now: GBX 240
Low: 238
High: 258

Volume

9,183 shs

Average Volume

24,474 shs

Market Capitalization

£66.44 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Arecor Therapeutics?

Arecor Therapeutics' top insider investors include:
  1. Andrew Richards (Insider)
"I've never seen anything bigger"
From Legacy Research   |   Ad
According to one Wall Street Legend, "for those who take early action, it could make 2021 one of your best years ever".
Watch more here!